Italy’s vaccine hopes: Italian firm IRBM group signs deal with Oxford University to develop vaccine

An Italian company that in the past joined the fight against Ebola has signed an agreement with Oxford University to develop a vaccine for coronavirus. The Oxford-AstraZeneca vaccine is one of 150 in development globally, but is considered the most advanced.
First trial results suggest that the vaccine produces a good immune response in volunteers without serious side-effects.
Euronews spoke to the Managing Director of the Italian company that worked on the project. Giorgia Orlandi reports. Subscribe to our channel: bit.ly/2nhQGgN Latests news : bit.ly/EuronewsTopStories Follow us on our thematic channels:
NoComment: www.youtube.com/c/nocommenttv?sub_confirmation=1
Euronews Living: bit.ly/2sMsaDB
Knowledge: www.youtube.com/c/euronewsknowledge?sub_confirmation=1: Follow us on all platforms and on all devices: www.euronews.com/follow-us
#GoodMorningEurope